Devices known as closed blood sampling systems minimize blood waste while lowering the possibility of contamination and the spread of infectious illnesses. The goal of closed blood sampling systems is to increase the process's efficiency. In particular, airborne pollutants are kept out of the bloodstream using closed blood sampling methods.
Excess in-line blood can be reinfused into the patient thanks to the design of closed blood sampling systems. In closed blood sampling systems, a reservoir stores blood and eliminates the need for repeated blood draws, particularly for critically ill patients who have experienced significant trauma or injuries.
Download a Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=4002
Key Opportunities for Closed Blood Sampling Equipment Manufacturers
The demand for needleless blood sampling systems is rising due to their ability to prevent needle-stick injuries and reduce infection risks, driving market growth. Innovations in systems designed for neonates and pediatric patients further enhance precision and safety in critical care, enabling accurate monitoring and outcomes.
The increasing prevalence of chronic illnesses has created opportunities for manufacturers to offer patient-specific solutions, enhancing care and safety. These trends support market growth and improved global patient outcomes.
Country-wise Insights
U.S. Market
The U.S. dominated the North American market with 91.2% share in 2021 and is expected to maintain strong growth due to rising awareness of safe blood sampling, reducing contamination and infection risks.
Germany Market
Germany is set to lead the European market, with a 23.5% share by 2032. High healthcare spending and the growing demand for advanced diagnostic systems drive this growth.
China Market
China held 43.3% of the East Asia market in 2021 and is expected to grow at a 7.6% CAGR. Its position as a key medical device manufacturing hub supports this expansion.
Competitive Landscape
Leading manufacturers of closed blood sampling systems are focusing on research and development, partnerships, and new product launches as key strategies for growth.
In January 2021, Inventis, an Italian company specializing in audiological diagnostics, acquired 100% of Synapsys, a French leader in balance diagnostic systems.
In June 2018, Interacoustics A/S introduced the Micromedical Orion Rotary Chair to improve vestibular assessment.
Recent developments from companies in the closed blood sampling sector have been tracked by Fact.MR, with details available in the full report.
Comments
0 comment